Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microglial activation refers to the process by which microglia, the resident immune cells of the central nervous system (CNS), transition from a surveillant or "resting" state to various reactive states in response to changes in their environment. This process is central to neuroinflammation and is implicated in both protective and pathological responses within the CNS. Activated microglia display a spectrum of phenotypes, including pro-inflammatory (M1) and anti-inflammatory (M2) states, and participate in cytokine release, phagocytosis, and antigen presentation. Microglial activation is implicated across numerous CNS pathologies and can be either beneficial or detrimental depending on context.
Modulation of microglial phenotype (e.g., shifting from M1 to M2)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microglial Activation (None).